Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...

The data, compiled by the nonprofit KFF Health News, found Connecticut received $85 million in opioid settlement funds in ...

Through his public-benefit corporation Star Syringe, Koska first needed to embark on a public policy and advocacy campaign to ...

Access Point Pueblo, a syringe access program, saw big improvements in its needle exchange rate in January. Here's what to ...

We believe there is minimal cause for concern with HIMS stock, which makes it attractive but highly sensitive to adverse events as its current valuation is extremely ...

LOUISVILLE, Ky. (WDRB) — Used needles are being found on and around a children's playground in Louisville's Portland ...

The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...

A local resident has called a large pile of items fly-tipped in on the Sirhowy walk from Crosskeys ‘absolutely disgusting’.

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

While marking the 50th anniversary of “Saturday Night Live,” the producers also highlighted 50 years since one of President ...

Harm reduction advocates are implementing solidarity-based strategies for curbing drug overdoses in Minneapolis.

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCEtm (60mg pre-filled syringe) and XBRYKtm (120mg vial), denosumab biosimilars ...